X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/08/06/2925421/0/en/Pliant-Therapeutics-to-Participate-in-the-Canaccord-Genuity-44th-Annual-Growth-Conference.html
https://www.globenewswire.com/news-release/2024/07/15/2912994/0/en/Pliant-Therapeutics-Announces-Positive-Long-Term-Data-from-the-INTEGRIS-PSC-Phase-2a-Trial-Demonstrating-Bexotegrast-was-Well-Tolerated-at-320-mg-with-Continued-Antifibrotic-and-An.html
https://www.globenewswire.com/news-release/2024/06/13/2898633/0/en/Pliant-Therapeutics-Announces-Appointment-of-Steve-Krognes-to-Board-of-Directors.html
https://www.globenewswire.com/news-release/2024/06/12/2897878/0/en/Pliant-Therapeutics-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html
https://www.globenewswire.com/news-release/2024/06/06/2894591/0/en/Pliant-Therapeutics-Presents-Data-from-its-Bexotegrast-Program-at-the-European-Association-for-the-Study-of-the-Liver-EASL-International-Liver-Congress.html
https://www.globenewswire.com/news-release/2024/05/21/2886108/0/en/Pliant-Therapeutics-Presents-Data-from-its-Bexotegrast-Program-at-the-American-Thoracic-Society-International-Conference.html
https://endpts.com/pliant-touts-additional-phase-2a-data-for-oral-ipf-drug-thats-already-in-a-pivotal-study/
https://www.globenewswire.com/news-release/2024/05/14/2881271/0/en/Pliant-Therapeutics-Announces-Positive-Topline-Data-from-a-Phase-2a-Collagen-PET-Imaging-Clinical-Trial-of-Bexotegrast-in-Patients-with-Idiopathic-Pulmonary-Fibrosis.html
https://www.globenewswire.com/news-release/2024/05/07/2876685/0/en/Pliant-Therapeutics-Announces-Upcoming-Presentations-at-the-European-Association-for-the-Study-of-the-Liver-International-Liver-Congress.html
https://www.globenewswire.com/news-release/2024/05/06/2876163/0/en/Pliant-Therapeutics-Provides-Corporate-Update-and-Reports-First-Quarter-2024-Financial-Results.html
Market Place
Share 
